Get started
Author

Alissa M. Michel

Observed names: A. Michel, Alissa M Michel, Alissa Michel, Michel, Alissa, Michel, Alissa M.
ORCID: 0000-0003-0829-9804
Observed ORCID: 0000-0003-0829-9804
OpenAlex ID: A5084730493
Breast cancer risk prediction combining a convolutional neural network-based mammographic evaluation with clinical factors
2023 · Alissa Michel, Vicky Ro, et al. · Breast Cancer Research and Treatment · 22
Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling
2023 · Alissa Michel, Richard T. Lee, et al. · American Society of Clinical Oncology Educational Book · 14
PDF
Cellular states associated with metastatic organotropism and survival in patients with pancreatic ductal adenocarcinoma
2025 · Morteza Chalabi Hajkarim, Michael May, et al. · Nature Genetics · 11
Cancer genetic mutation prevalence in sub-Saharan Africa: A review of existing data
2023 · Joshua Shain, Alissa Michel, et al. · Seminars in Oncology · 6
The breast cancer genetic testing experience: probing the potential utility of an online decision aid in risk perception and decision making
2025 · Anna Vaynrub, Brian Salazar, et al. · BMC Cancer · 4
PDF
Time to Cancer Treatment and Chemotherapy Relative Dose Intensity for Patients With Breast Cancer Living With HIV
2023 · Daniel S. O’Neil, Yehoda M. Martei, et al. · JAMA Network Open · 4
PDF
Smoking is Not Associated with Lung Metastasis in Pancreatic Cancer
2023 · Michael S. May, Jacob K. Jamison, et al. · Cancer Investigation · 4
PDF
Use of web-based decision support to improve informed choice for chemoprevention: a qualitative analysis of pre-implementation interviews (SWOG S1904)
2024 · Alissa M. Michel, Haeseung Yi, et al. · BMC Medical Informatics and Decision Making · 3
PDF
A Colorectal Cancer Screening Programs in Middle-Income Countries: A Scoping Review
2023 · Alissa Michel, Yoanna Pumpalova · Medical Research Archives · 3
PDF
Factors Associated with Low-Dose Tamoxifen Use among Women with Atypical Hyperplasia or Lobular or Ductal Carcinoma In Situ
2025 · Maya S. Deshmukh, Margaret H. Kyle, et al. · Cancer Prevention Research · 2
Factors associated with receipt of surveillance breast MRI among racially and ethnically diverse women with operable breast cancer
2025 · Preeti Kakani, Vicky Ro, et al. · Breast Cancer Research and Treatment · 2
Perceptions of Chemoprevention Among Women at High Risk for Breast Cancer
2026 · Romi Eli, Harry West, et al. · JAMA Network Open · 1
Abstract PS3-01-15: Making informed choices on incorporating chemoprevention into care (MiCHOICE): Cluster randomized controlled trial of decision support for breast cancer chemoprevention, SWOG 1904
2026 · K. D. Crew, G. L. Anderson, et al. · Clinical Cancer Research · 1
Provider and information technology operations staff perspectives on the feasibility of writing patient-generated health data into the electronic health record
2025 · Aman Saiju, Subiksha Umakanth, et al. · JAMIA Open · 1
Comparing Breast Cancer and Cardiovascular Risk among Women Undergoing Screening Mammography: Why Are Statins More Widely Accepted Compared with Chemoprevention?
2025 · Peter J. Zeiger, Vicky Ro, et al. · Cancer Prevention Research · 1
Neoadjuvant gemcitabine, docetaxel, and capecitabine results in comparable surgical outcomes to modified FOLFIRINOX in patients with pancreatic ductal adenocarcinoma who also receive radiation: A single institution experience.
2022 · Winston Wong, Jacob K.R. Jamison, et al. · Journal of Clinical Oncology · 1
Implementation needs for expanding oncologist-led germline genetic testing: A qualitative analysis of patients and clinicians.
2026 · Vicky Ro, Zoe Bell, et al. · JCO Oncology Practice
PDF
Somatic-to-germline concordance rates in clinically actionable cancer predisposition genes.
2026 · Abigail Macher, Zihan Xiong, et al. · JCO Oncology Practice
PDF
Fragmented ownership and multilevel barriers to breast MRI screening among high-risk women: A qualitative study informing development of clinical decision support
2026 · Marlee Pincus, Cynthia Law, et al. · Research Square
PDF
Male breast cancer: from extrapolated practice to evidence-based care
2026 · Bethina Liu, Alissa M Michel, et al. · The Oncologist
Cluster randomized controlled trial of decision support for breast cancer chemoprevention, MiCHOICE
2026 · Katherine D Crew, Garnet L Anderson, et al. · JNCI Journal of the National Cancer Institute
Patient Experiences with Oncologist-Mediated Genetic Testing: A Qualitative Study of Understanding, Engagement, and Family Communication
2026 · Bell, Zoe, Michel, Alissa M., et al. · Columbia Academic Commons (Columbia University)
Impact of telehealth genetic counseling on contralateral prophylactic mastectomy rates among multi-ethnic breast cancer patients
2026 · Alissa Michel, Vicky Ro, et al. · npj Women s Health
PDF
Supplementary Table 1 from Factors Associated with Low-Dose Tamoxifen Use among Women with Atypical Hyperplasia or Lobular or Ductal Carcinoma In Situ
2026 · Maya S. Deshmukh, Margaret H. Kyle, et al.
Data from Factors Associated with Low-Dose Tamoxifen Use among Women with Atypical Hyperplasia or Lobular or Ductal Carcinoma In Situ
2026 · Maya S. Deshmukh, Margaret H. Kyle, et al.
Works count: 45
Citation count: 76
H-index: 4
I10-index: 3
Year
Topic
Type